## 29769 Federal Register/ Vol. 75, No. 102 / Thursday, May 27, 2010 / Notices

requirements of the applicable statutes and regulations. II. Paperwork Reduction Act of 1995

This guidance refers to previously approved collections of information found in FDA regulations. These collections of information are subject to review by the Office of Management and Budget (OMB) under the Paperwork Reduction Act of 1995 (44 U.S.C. 3501– 3520). The collections of information in 21 CFR 601.12 have been approved under OMB control number 0910–0338; the collections of information in 21 CFR 606.100 have been approved under OMB control number 0910–0116; and the collections of information in 21 CFR Part 600.14 and 606.171 have been approved under OMB control number
0910–0458.

III. Comments

Interested persons may, at any time, submit to the Division of Dockets Management (see **ADDRESSES**

### ) electronic or written comments regarding the guidance. Submit a single copy of electronic comments or two paper copies of any mailed comments, except that individuals may submit one paper copy. Comments are to be identified with the docket number found in brackets in the heading of this document. A copy of the guidance and received comments are available for public examination in the Division of Dockets Management between 9 a.m. and 4 p.m., Monday through Friday.

IV. Electronic Access

Persons with access to the Internet may obtain the guidance at either http:// www.fda.gov/BiologicsBloodVaccines/ GuidanceComplianceRegulatory Information/Guidances/default.htm or http://www.regulations.gov

.

Dated: May 18, 2010. Leslie Kux, Acting Assistant Commissioner for Policy.
[FR Doc. 2010–12696 Filed 5–26–10; 8:45 am]

**BILLING CODE 4160–01–S**



### DEPARTMENT OF HEALTH AND **HUMAN SERVICES**

**Agency for Healthcare Research and Quality** 

**Notice of Meetings**

In accordance with section 10(d) of the Federal Advisory Committee Act as amended (5 U.S.C., Appendix 2), the Agency for Healthcare Research and Quality (AHRQ) announces meetings of scientific peer review groups. The subcommittees listed below are part of the Agency’s Health Services Research Initial Review Group Committee.

The subcommittee meetings will be closed to the public in accordance with the Federal Advisory Committee Act, section 10(d) of 5 U.S.C., Appendix 2 and 5 U.S.C. 552b(c)(6). Grant applications are to be reviewed and discussed at these meetings. These discussions are likely to involve information concerning individuals associated with the applications, including assessments of their personal qualifications to conduct their proposed projects. This information is exempt from mandatory disclosure under the above-cited statutes.

1. Name of Subcommittee: Health Care Technology and Decision Sciences.

Date: June 15–17, 2010 (Open from 8 a.m. to 8:15 a.m. on June 15 and closed for remainder of the meeting)

Place: Crowne Plaza Hotel, 3 Research Court, Conference Room TBD, Rockville, MD

20852.

2. Name of Subcommittee: Health Systems Research.

Date: June 16–18, 2010 (Open from 8 a.m. to 8:15 a.m. on June 16 and closed for remainder of the meeting)

Place: Sheraton Rockville Hotel, 920 King Farm Boulevard, Conference Room TBD, Rockville, MD 20852.

3. Name of Subcommittee: Health Care Research Training.

Date: June 17–18, 2010 (Open from 8 a.m. to 8:15 a.m. on June 17 and closed for remainder of the meeting)

Place: Hyatt Regency Hotel, 7400 Wisconsin Avenue, 1 Bethesda Metro Center, Conference Room TBD, Bethesda, Maryland

20814.

4. Name of Subcommittee: Health Care Quality and Effectiveness Research.

Date: June 22–24, 2010 (Open from 8:30 a.m. to 8:45 a.m. on June 22 and closed for remainder of the meeting)

Place: Hilton Rockville Executive Meeting Center, 1750 Rockville Pike, Conference Room TBD, Rockville, Maryland 20850.

Contact Person: Anyone wishing to obtain a roster of members, agenda or minutes of the nonconfidential portions of the meetings should contact Mrs. Bonnie Campbell, Committee Management Officer, Office of Extramural Research, Education and Priority Populations, AHRQ, 540 Gaither Road, Suite 2000, Rockville, Maryland 20850, Telephone (301) 427–1554.

Agenda items for these meetings are subject to change as priorities dictate.

Dated: May 13, 2010. Carolyn M. Clancy,

Director.
[FR Doc. 2010–12547 Filed 5–26–10; 8:45 am]

**BILLING CODE 4160–90–M** 

### DEPARTMENT OF HEALTH AND **HUMAN SERVICES**

**National Institutes of Health**

**National Cancer Institute; Notice of Closed Meetings** 

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings.

The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and/or contract proposals and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications and/or contract proposals, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

Name of Committee: National Cancer Institute Special Emphasis Panel; Integrating Patient-Reported Outcomes in Hospice and Palliative Care Practices.

Date: June 1, 2010. Time: 11 a.m. to 2 p.m. Agenda: To review and evaluate contract proposals.

Place: National Cancer Institute, 6116 Executive Blvd., Room 8018, Bethesda, MD 20892 (Telephone Conference Call).

Contact Person: Shamala K. Srinivas, PhD, Scientific Review Officer, Research Programs Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 6116 Executive Boulevard, Room 8123, Bethesda, MD 20892, 301–594–1224, ss537t@nih.gov.

This notice is being published less than 30 days prior to the meeting due to scheduling conflicts.

Name of Committee: National Cancer Institute Special Emphasis Panel; Development of Anticancer Agents.

Date: June 2, 2010. Time: 2 p.m. to 4 p.m. Agenda: To review and evaluate contract proposals.

Place: National Institutes of Health, 6116 Executive Boulevard, Room 8018, Rockville, MD 20852 (Telephone Conference Call).

Contact Person: Joyce C. Pegues, B.S., B.A., PhD, Scientific Review Officer, Special Review and Logistics Branch, Division of Extramural Activities, National Cancer Institute, NIH, 6116 Executive Boulevard, Room 7149, Bethesda, MD 20892–8329, 301–594–1286, peguesj@mail.nih.gov.

This notice is being published less than 30 days prior to the meeting due to scheduling conflicts. (Catalogue of Federal Domestic Assistance Program Nos. 93.392, Cancer Construction; 93.393, Cancer Cause and Prevention Research; 93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer